Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Novozymes Biopharma, part of Novozymes A/S, has formed a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma's engineered albumin-based VELTIS...

Novartis has announced the launch of the Lucentis® (ranibizumab) prefilled syringe (PFS) in Germany, with other markets to follow throughout 2014. The Lucentis PFS, which received European approval in October 2013, is a new way of administering...

Shire Pharmaceuticals has initated a voluntary recall in the United States of one batch, packaged into three lots, of VPRIV, a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for...

UCB and Sanofi have entered into a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules that have the potential to treat a wide range of immune-mediated diseases in areas such...

Takeda Pharmaceutical Company Limited has made organizational and reporting line changes in line with Christophe Weber's assumption as Takeda's chief operating officer (COO) as of April 1, 2014, which the company had previously announced....

Amgen has appointed David Piacquad to the new position of senior vice-president, business development. Piacquad will report directly to Robert A. Bradway, chairman and chief executive officer and will be responsible for business development across...

With an investment of more than EUR 500 million ($695 million) at its sites in Wuppertal and Leverkusen, Germany, Bayer will establish additional capacities for the manufacturing of the recombinant factor VIII (rFVIII) hemophilia products that are...

AstraZeneca has agreed to sell its Alderley Park site in Cheshire, United Kingdom (UK) to Manchester Science Parks, a Greater Manchester-based public-private partnership and science park operator. The sale is part of AstraZeneca's...

Almac is expanding its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. Almac is strengthening its Asia Pacific offerings by establishing a new...